Exact Sciences (NASDAQ:EXAS) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Exact Sciences Stock (NASDAQ: EXAS) stock price, news, charts, stock research, profile.

Open	$68.68
Close	-
Volume / Avg.	568.32K / 2.77M
Day Range	$66.79 - $68.68
52 Wk Range	40.62 - 79.62
Market Cap	$12.52B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	8.97%
Days to Cover	5.26

Recent News

Chewy, Broadcom And MicroStrategy Are Among Top 10 Large Cap Stock Gainers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?

These ten stocks saw significant gains last week, with Summit Therapeutics up 98.32% and BioNTech up 31.77%. Analysts also raised price targets for Applovin and Arm Holdings.

Lekha Gupta

Exact Sciences To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Thursday

Avi Kapoor

Wall Street Analysts Believe Exact Sciences Could Rally 34.33%: Here's is How to Trade

Exact Sciences (NASDAQ: EXAS) closed the last trading session at $59.11, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $79.40 indicates a 34.3% upside potential.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jun

Jul

Aug

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$68.68
Close	-
Volume / Avg.	568.32K / 2.77M
Day Range	$66.79 - $68.68
52 Wk Range	40.62 - 79.62
Market Cap	$12.52B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	8.97%
Days to Cover	5.26

About Exact Sciences Corp.

Sector

Health Care

Industry

Biotechnology

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagn...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Exact Sciences (EXAS) stock?

You can purchase shares of Exact Sciences (NASDAQ:EXAS) through any online brokerage.

View our list of the best stock brokerages

Who are Exact Sciences (EXAS) competitors?

Other companies in Exact Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Exact Sciences (EXAS) stock?

Exact Sciences has a consensus price target of $81.68.

What is the current price for Exact Sciences (EXAS)?

The stock price for Exact Sciences (NASDAQ: EXAS) is $67.75 last updated September 25, 2024 at 12:54 PM EDT.

Does Exact Sciences (EXAS) pay a dividend?

There are no upcoming dividends for Exact Sciences.

When is Exact Sciences (NASDAQ:EXAS) reporting earnings?

Exact Sciences’s Q3 earnings are confirmed for Wednesday, October 30, 2024.

Is Exact Sciences (EXAS) going to split?

There is no upcoming split for Exact Sciences.

What sector and industry does Exact Sciences (EXAS) operate in?

Exact Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge